Introduction: Cervical cancer (CC) is currently the fourth most common malignant disease of
women worldwide. Although the incidence and the mortality rates have been decreasing …

Cervical cancer is the leading gynecologic health problem which is considered as the 4th
most widespread tumour in women. The prevalence of this fatal ailment is emerging …

Importance of the field: Cervical cancer (CC) remains an important health problem. It is the
second most frequent malignancy in women worldwide, with one-third of patients dying from …

Cervical cancer is the second most frequent malignancy affecting women worldwide. The
highest incidences occur in the developing world, where, in most countries, cervical cancer …

Cervical cancer represents the third most common cause of female cancer mortality. Even
with the best currently available treatment, a significant proportion of patients will experience …

Cervical cancer is the third most common cancer worldwide, and the development of new
diagnosis, prognostic, and treatment strategies is a major interest for public health. Cisplatin …

Cervical cancer is the fourth most common cancer in women worldwide, with a global
incidence of 604,127 and an annual death rate of 341,831 in 2020. Patients with recurrent …

Effective cytotoxic treatment options for advanced cervical cancer are exceedingly limited.
Cisplatin-based combination chemotherapy, the most commonly used cytotoxic therapy, has …

Background: Cancer is the second leading cause of death among men and women and a
highly prevalent cause of mortality among women. Having sexual relations at a young age …

Introduction: There is a shortage of therapeutical agents for invasive cervical cancer in late
stages of development; however, a number of promising molecules are currently in early …